Company: PFSA
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065686
Chunk: 40

Company: Profusa, Inc.
Filing Date: 2025-07-18
Form: 8-K
Chunk 40
---
 (1,625 | )% |
| Interest expense                                                                |     |                    | (1,230 | ) |     |      | (1,080 | ) |     |        | (150 | ) |     |   |     14 | %  |
| Other income (expense)                                                          |     |                    |     (1 | ) |     |      |      5 |   |     |        |   (6 | ) |     |   |   (120 | )% |
| Total other expense, net                                                        |     |                    | (1,292 | ) |     |      | (1,071 | ) |     |        | (221 | ) |     |   |     21 | %  |
| Net loss                                                                        |     |                  $ | (2,716 | ) |     |    $ | (2,385 | ) |     | $      | (331 | ) |     |   |     14 | %  |

Research and Development –
Research and development expenses decreased by $0.1 million, or 14%, to $0.4 million during the three months ended March 31, 2025 from
$0.5 million during the three months ended March 31, 2024. The decrease was driven primarily by the decrease in CRO and personnel costs
of $0.1 million as a result of the completion of several clinical studies and a reduction of personnel.

General and Administrative –
General and administrative expenses increased by $0.2 million, or 19%, to $1.0 million during the three months ended March 31, 2025 from
$0.8 million during the three months ended March 31, 2024. The increase was driven primarily by the increase in accounting costs of $0.3
million as a result of increased audit fees, which was offset by a reduction in legal fees of $0.1 million as a result of legal fees being
incurred primarily on the merger transaction which are deferred offering costs and not part of general and administrative expenses.

Gain (Loss) on Change in the Fair Value of Related Party Tasly Convertible Debt– Loss on change in the fair value of the Tasly Convertible Loan was $0.1 million
during the three months ended March 31, 2025, driven by the remeasurement of the Tasly Convertible Loans. There was no such loss during
the three months ended March 31,